Be a Smart Investor
Monday, February 25, 2019
There will be continued interest in gene therapy, says biotech analyst
CNBC's "Power Lunch" team discusses whether there's more biotech buyouts ahead with Michael Yee of Jefferies.
from Deals and IPOs https://ift.tt/2Tgb5kc
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment